UNC119B Human

UNC-119 Homolog B Human Recombinant
Shipped with Ice Packs
In Stock

Description

Domain Architecture

UNC119B adopts an immunoglobulin-like β-sandwich fold, forming a hydrophobic pocket that binds myristoylated cargo proteins. This structure is conserved across GSFs but includes unique features:

  • A stretch of negatively charged residues (residues 120–135) not found in UNC119A .

  • Enhanced conformational flexibility in the C-terminal region, enabling interactions with release factors like ARL3 .

Biochemical Mechanisms

Cargo Binding and Release

UNC119B binds N-myristoylated proteins with a wide range of affinities (K<sub>d</sub> values from 0.17 nM to 5.25 nM) . Key findings include:

  • High-affinity cargoes: LCK (lymphocyte-specific kinase) binds UNC119B with 0.37 nM affinity, slightly tighter than UNC119A (0.83 nM) .

  • Release factors: ARL3-GTP triggers cargo release from UNC119B 2–10× more efficiently than ARL2 .

Table 2: Binding Affinities of Select Cargoes

Cargo PeptideUNC119B K<sub>d</sub> (nM)UNC119A K<sub>d</sub> (nM)Fold Difference
LCK0.370.832.2×
NPHP30.170.844.9×
PCMTD15.250.3913.5×

Cellular Roles and Pathways

Trafficking to the Primary Cilium

UNC119B is essential for localizing nephrocystin-3 (NPHP3) to the cilium membrane via ARL3-GTP-mediated release . Knockdown of UNC119B disrupts ciliary targeting, leading to developmental defects in zebrafish .

Immunological Synapse Formation

In T cells, UNC119B shuttles LCK to the immunological synapse (IS), enabling T-cell receptor (TCR) signaling. Inhibition of UNC119B reduces LCK polarization, impairing ZAP70 phosphorylation and T-cell activation .

Disease Associations

T-Cell Acute Lymphocytic Leukemia (T-ALL)

UNC119B sustains proliferation in T-ALL cell lines by regulating LCK localization. Pharmacological inhibition of UNC119B reduces tumor cell growth without compromising cytotoxic T-lymphocyte (CTL) function, suggesting therapeutic potential .

Ciliopathies

Mutations in UNC119B-linked pathways (e.g., ARL3, NPHP3) are implicated in ciliopathies such as Joubert syndrome and retinitis pigmentosa .

6. Structural Insights from Crystallography
The first crystal structures of UNC119B (PDB: 7OK6, 7OK7) reveal:

  • Cargo-bound state: The LCK peptide binds via hydrophobic interactions and hydrogen bonds to residues Y100 and E134 .

  • ARL3-bound state: ARL3 binding induces a conformational shift in UNC119B’s charged loop (residues 120–135), facilitating cargo release .

7. Functional Partners and Pathways
Table 3: Key Interactors of UNC119B

ProteinRole in UNC119B PathwayInteraction Type
ARL3GTPase triggering cargo releaseDirect binding (K<sub>d</sub> = 33 nM)
NPHP3Ciliary cargo proteinMyristoyl-dependent binding
RP2ARL3-GAP; enhances cargo releaseIndirect regulation

Product Specs

Introduction
UCN119B, a member of the PDE6D/unc-119 family, is found in high concentrations in the photoreceptors of the retina. This protein shares significant similarities with the C. elegans unc119 gene and can compensate for its absence in mutated C. elegans organisms.
Description
Recombinant human UNC119B, produced in E. coli, is a non-glycosylated polypeptide chain consisting of 271 amino acids (1-251) with a molecular weight of 30.3 kDa. This protein is expressed with an N-terminal 20 amino acid His-tag and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile filtered solution.
Formulation
The UNC119B solution is provided at a concentration of 0.5 mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 100mM NaCl, 1mM DTT, and 10% glycerol.
Stability
For short-term storage (up to 4 weeks), keep at 4°C. For extended periods, store frozen at -20°C. Adding a carrier protein such as 0.1% HSA or BSA is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
Purity exceeds 90% as determined by SDS-PAGE analysis.
Synonyms
Unc-119 homolog B (C. elegans), POC7B, POC7 centriolar protein homolog B, MGC5139.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MSGSNPKAAA AASAAGPGGL VAGKEEKKKA GGGVLNRLKA RRQAPHHAAD DGVGAAVTEQ ELLALDTIRP EHVLRLSRVT ENYLCKPEDN IYSIDFTRFK IRDLETGTVL FEIAKPCVSD QEEDEEEGGG DVDISAGRFV RYQFTPAFLR LRTVGATVEF TVGDKPVSNF RMIERHYFRE HLLKNFDFDF GFCIPSSRNT CEHIYEFPQL SEDVIRLMIE NPYETRSDSF YFVDNKLIMH NKADYAYNGG Q

Q&A

What is UNC119B and what is its primary biological function?

UNC119B is a myristoyl-binding protein that acts as a cargo adapter in cellular trafficking pathways. It specifically binds the myristoyl moiety of a subset of N-terminally myristoylated proteins and is required for their proper localization within cells . One of its most well-characterized roles involves binding myristoylated NPHP3 (Nephronophthisis 3), where it plays a key role in localizing this protein to the primary cilium membrane . UNC119B demonstrates cargo selectivity, as it does not bind all myristoylated proteins indiscriminately . Evidence also suggests UNC119B is involved in protein trafficking within photoreceptor cells, indicating potential importance in visual function and retinal biology .

Where is the UNC119B gene located in the human genome?

The UNC119B gene maps to chromosome 12q24.31 in the human genome . This chromosomal location information is essential for genetic studies investigating potential associations with disease conditions that may map to this region. Understanding the genomic context of UNC119B provides valuable insights for researchers designing gene targeting experiments or analyzing genetic variants in this locus.

To which protein family does UNC119B belong?

UNC119B belongs to the PDE6D/unc-119 protein family . This classification provides important context for comparative studies with other family members and can help researchers predict functional properties based on conserved domains within this family. The evolutionary relationship with unc-119, originally identified in C. elegans, suggests conservation of function across species and provides a framework for cross-species comparative studies.

What are the key structural characteristics of UNC119B protein?

UNC119B is a full-length human protein consisting of 251 amino acids . When expressed recombinantly in Escherichia coli, it can be produced with high purity (>90%) . The protein contains a binding pocket specialized for accommodating myristoyl modifications, which is critical for its function as a cargo adapter. Recombinant UNC119B can be engineered with tags (such as a histidine tag) to facilitate purification and is suitable for analytical techniques including SDS-PAGE and mass spectrometry .

What are the optimal methods for expressing and purifying recombinant UNC119B?

Successful expression and purification of recombinant UNC119B typically involves the following methodological considerations:

Expression System Optimization:

  • Escherichia coli has been successfully employed as an expression host for UNC119B

  • Expression constructs typically include a histidine tag to facilitate purification

  • Optimal expression conditions may include:

    • Growth at lower temperatures (16-25°C) to enhance solubility

    • Induction with appropriate IPTG concentrations (0.1-0.5 mM)

    • Extended expression times (overnight) at reduced temperatures

Purification Strategy:

  • Immobilized metal affinity chromatography (IMAC) using the His-tag

  • Buffer optimization to maintain protein stability (typically including:

    • pH range: 7.0-8.0

    • Salt concentration: 150-300 mM NaCl

    • Reducing agents: DTT or TCEP

    • Stabilizing agents: 5-10% glycerol)

  • Quality control via SDS-PAGE and mass spectrometry to confirm purity and identity

For applications requiring higher purity, additional chromatographic steps such as size exclusion or ion exchange chromatography may be incorporated into the workflow.

How can CRISPR/Cas9 technology be applied to study UNC119B function?

CRISPR/Cas9 technology offers powerful approaches for investigating UNC119B function through precise genome editing:

UNC119B Knockout Generation:
The UNC119B Double Nickase Plasmid system provides a targeted approach for disrupting gene expression in human cells . This system:

  • Utilizes a pair of plasmids, each encoding D10A mutated Cas9 nuclease and unique target-specific guide RNAs

  • Creates highly specific double nicking of the UNC119B gene, mimicking a double-strand break

  • Enables disruption of UNC119B expression with reduced off-target effects compared to standard CRISPR approaches

Methodological Workflow:

  • Transfect target cells with the UNC119B Double Nickase Plasmid pair

  • Select successfully transfected cells using appropriate markers

  • Isolate and expand clonal cell populations

  • Validate knockout efficiency at genomic, transcript, and protein levels

  • Analyze phenotypic consequences, particularly focusing on:

    • Primary cilium formation and function

    • Trafficking and localization of known UNC119B cargo proteins

    • Cell type-specific effects (e.g., in photoreceptor models)

Advanced CRISPR Applications:
Beyond knockout generation, researchers can employ CRISPR technology for:

  • Creating precise point mutations to study specific functional domains

  • Introducing fluorescent tags at the endogenous locus for live-cell imaging

  • Implementing CRISPRi/CRISPRa approaches for reversible modulation of expression

How does UNC119B inhibition affect protein localization to the primary cilium?

UNC119B plays a critical role in the ciliary targeting of specific myristoylated proteins, particularly NPHP3 . To investigate this function:

Experimental Approaches:

  • Generate UNC119B-deficient cellular models using CRISPR/Cas9 or RNAi techniques

  • Analyze localization of known cargo proteins (particularly NPHP3) via immunofluorescence microscopy

  • Quantify ciliary localization efficiency compared to control cells

  • Assess cilium formation and morphology using ciliary markers (e.g., acetylated tubulin)

Rescue Experiments:
To confirm specificity of observed phenotypes:

  • Re-express wild-type UNC119B in knockout cells

  • Test structure-function relationships using UNC119B variants with mutations in key domains

  • Analyze restoration of proper protein localization to the cilium

Expected Outcomes:
In UNC119B-deficient cells, researchers typically observe:

  • Significant reduction in ciliary localization of specific cargo proteins (NPHP3)

  • Relatively normal localization of non-UNC119B-dependent ciliary proteins

  • Potential secondary effects on cilium structure or function depending on cell type

What methods exist for studying UNC119B's interaction with myristoylated proteins?

Multiple complementary approaches can be employed to investigate UNC119B-myristoylated protein interactions:

Biochemical Interaction Assays:

  • Pull-down assays: Using immobilized recombinant UNC119B to capture myristoylated binding partners

  • Co-immunoprecipitation: Isolating UNC119B complexes from cells to identify interacting proteins

  • Surface Plasmon Resonance (SPR): For determining binding kinetics and affinity parameters

  • Isothermal Titration Calorimetry (ITC): To measure thermodynamic parameters of the interaction

Structural Biology Approaches:

  • X-ray crystallography: To determine the three-dimensional structure of UNC119B-myristoylated peptide complexes

  • NMR spectroscopy: For mapping binding interfaces and studying dynamic aspects of the interaction

Cellular Assays:

  • Fluorescence microscopy: To visualize co-localization of UNC119B with cargo proteins

  • Proximity ligation assays: For detecting protein-protein interactions in situ

  • FRET-based biosensors: To monitor interactions in living cells

When designing these experiments, researchers should include appropriate controls:

  • Non-myristoylated variants of potential cargo proteins

  • UNC119B mutants with alterations in the myristoyl-binding pocket

  • Unrelated myristoylated proteins known not to interact with UNC119B

What approaches are recommended for investigating UNC119B's role in photoreceptor cells?

UNC119B is implicated in protein trafficking within photoreceptor cells , which requires specialized experimental approaches:

Model Systems:

  • Retinal cell cultures: Primary cultures from model organisms or established photoreceptor cell lines

  • Retinal organoids: Derived from human induced pluripotent stem cells (iPSCs)

  • Animal models: Including conditional UNC119B knockout mice with retina-specific inactivation

Analytical Methods:

  • Immunohistochemistry: To examine UNC119B localization and distribution of potential cargo proteins

  • Electron microscopy: For ultrastructural analysis of photoreceptor organization

  • Electrophysiology: To assess functional consequences on photoreceptor signaling

  • Proteomics: To identify photoreceptor-specific UNC119B-interacting proteins

Experimental Design Considerations:

  • Include appropriate developmental timepoints, as photoreceptor maturation is a complex process

  • Combine morphological and functional assessments

  • Consider potential compensatory mechanisms (e.g., UNC119A function)

  • Compare findings across different model systems to establish conserved functions

How should researchers interpret changes in protein trafficking patterns following UNC119B manipulation?

When analyzing protein trafficking alterations after UNC119B knockout, knockdown, or overexpression, researchers should consider:

Quantitative Analysis Framework:

  • Establish clear metrics for quantifying trafficking defects:

    • Percentage of cells with ciliary localization of cargo proteins

    • Fluorescence intensity ratios between ciliary and cytoplasmic compartments

    • Kinetic parameters of protein movement using live-cell imaging

  • Apply appropriate statistical analyses:

    • Use paired tests when comparing the same cells before/after treatment

    • Apply ANOVA for multi-condition comparisons

    • Consider non-parametric tests if data do not meet normality assumptions

Interpretation Guidelines:

  • Direct vs. indirect effects:

    • Distinguish between primary effects on known UNC119B cargo proteins and secondary consequences

    • Consider potential compensatory mechanisms (especially UNC119A upregulation)

    • Verify specificity through rescue experiments with wild-type UNC119B

  • Context-dependent variations:

    • Account for cell type-specific differences in trafficking machinery

    • Consider cell cycle stage and cilium assembly status

    • Evaluate potential cross-talk with other trafficking pathways

  • Technical considerations:

    • Normalize for variations in expression levels of cargo proteins

    • Account for potential artifacts from protein tagging strategies

    • Control for transfection/transduction efficiency in heterogeneous populations

What controls are essential when analyzing UNC119B binding specificity data?

Rigorous controls are critical for accurately interpreting UNC119B binding specificity:

Essential Control Experiments:

  • Positive and negative controls:

    • Include known UNC119B interactors (e.g., myristoylated NPHP3) as positive controls

    • Use non-myristoylated variants of cargo proteins as negative controls

    • Include unrelated myristoylated proteins not expected to bind UNC119B

  • Specificity validation:

    • Compete binding with increasing concentrations of unlabeled ligands

    • Use UNC119B mutants with altered binding pocket residues

    • Compare binding to related proteins (e.g., UNC119A)

Control TypePurposeImplementation
Positive controlConfirms assay functionalityKnown UNC119B interactor (e.g., myristoylated NPHP3)
Negative controlEstablishes background signalNon-myristoylated variant of cargo protein
Competition assayVerifies binding specificityPre-incubation with unlabeled myristoylated peptides
Binding site mutantConfirms binding mechanismUNC119B with mutations in myristoyl-binding pocket
Orthogonal methodValidates findingsConfirm interactions with multiple techniques

Data Analysis Considerations:

  • Report both absolute and relative binding measurements

  • Include saturation binding experiments to determine maximum binding capacity

  • Present binding curves rather than single-point measurements

  • Report dissociation constants (Kd) with appropriate confidence intervals

How can researchers address issues with recombinant UNC119B solubility?

When encountering solubility challenges with recombinant UNC119B:

Expression Optimization:

  • Reduce induction temperature (16-20°C) to slow protein synthesis and promote proper folding

  • Decrease inducer concentration to reduce expression rate

  • Co-express molecular chaperones to assist folding

  • Consider fusion partners known to enhance solubility (MBP, SUMO, Thioredoxin)

Buffer Optimization:

  • Screen buffer conditions systematically:

    • pH range (typically 6.5-8.5)

    • Salt concentration (150-500 mM NaCl)

    • Adding stabilizing agents:

      • Glycerol (5-20%)

      • Mild detergents (0.01-0.1% Triton X-100)

      • Arginine (50-100 mM)

Purification Strategy Adjustments:

  • Include reducing agents if UNC119B contains cysteine residues

  • Consider on-column refolding procedures

  • Optimize elution conditions to maintain solubility

  • Perform buffer exchange gradually to avoid precipitation

Storage Recommendations:

  • Maintain protein at moderate concentration (1-2 mg/ml)

  • Add stabilizing agents for long-term storage

  • Aliquot to avoid repeated freeze-thaw cycles

  • Validate activity after storage to ensure functionality is preserved

What strategies can address inconsistent phenotypes in UNC119B knockout experiments?

When facing variable phenotypes in UNC119B knockout studies:

Validation of Knockout Efficiency:

  • Confirm complete elimination of protein expression via Western blot

  • Verify genomic alterations by sequencing the targeted region

  • Check for potential alternative splicing that might generate truncated proteins

  • Assess expression of related proteins (particularly UNC119A) that might compensate

Experimental Design Refinements:

  • Generate and characterize multiple independent knockout clones

  • Include wild-type control cells that have undergone similar selection processes

  • Consider potential clonal variations unrelated to UNC119B status

  • Implement acute knockout strategies (e.g., inducible systems) to minimize adaptation

Phenotypic Analysis Standardization:

  • Establish clear, quantitative criteria for phenotype assessment

  • Blind analysis to eliminate observer bias

  • Ensure consistent timing for phenotype evaluation

  • Control for environmental variables (cell density, passage number, serum lot)

Rescue Experiment Design:

  • Re-express UNC119B at physiological levels (avoid overexpression)

  • Include appropriate controls (empty vector, inactive UNC119B mutant)

  • Verify expression levels and localization of the rescue construct

  • Test multiple independent rescue clones

What are the most promising applications of UNC119B research in human disease studies?

UNC119B research holds significant potential for understanding and addressing several human disease contexts:

Ciliopathy Research:
Given UNC119B's role in ciliary protein trafficking , it may contribute to understanding mechanisms underlying:

  • Nephronophthisis and related kidney disorders

  • Retinal degenerative diseases

  • Bardet-Biedl syndrome and other ciliopathy spectrum disorders

Therapeutic Development Directions:

  • Exploring small molecule modulators of UNC119B-cargo interactions

  • Investigating gene therapy approaches for UNC119B-related disorders

  • Developing targeted protein degradation strategies for precise modulation of UNC119B function

Diagnostic Applications:

  • Identifying UNC119B mutations or expression changes as disease biomarkers

  • Developing functional assays to assess UNC119B pathway integrity

  • Creating screening platforms for compounds that restore normal trafficking

Emerging Research Areas:

  • Investigating UNC119B's potential role in cancer cell biology

  • Exploring connections to neurodegenerative disease mechanisms

  • Examining UNC119B function in immune cell signaling and inflammation

Which emerging technologies show the most promise for advancing UNC119B functional studies?

Several cutting-edge technologies are poised to significantly advance UNC119B research:

Advanced Imaging Technologies:

  • Super-resolution microscopy: Techniques like STORM, PALM, and STED can resolve UNC119B-mediated trafficking events below the diffraction limit

  • Lattice light-sheet microscopy: Enables high-speed 3D imaging with minimal phototoxicity for tracking dynamic trafficking processes

  • Cryo-electron microscopy: For determining high-resolution structures of UNC119B-cargo complexes

Genome Engineering Advances:

  • Base editing and prime editing: For introducing precise mutations without double-strand breaks

  • CRISPR screening platforms: To identify genes that functionally interact with UNC119B

  • Inducible degradation systems: For acute and reversible depletion of UNC119B protein

Proteomics and Interaction Mapping:

  • Proximity labeling technologies: Enhanced BioID and APEX2 approaches for identifying transient interactions

  • Crosslinking mass spectrometry: For capturing and identifying interaction interfaces

  • Single-molecule techniques: For directly visualizing UNC119B-cargo binding events

Systems Biology Integration:

  • Multi-omics approaches: Combining transcriptomics, proteomics, and metabolomics data

  • Mathematical modeling: To predict trafficking dynamics and network behaviors

  • Machine learning applications: For analyzing complex trafficking patterns and predicting functional consequences of genetic variants

Product Science Overview

Gene and Protein Structure

The UNC119B gene encodes a protein that is composed of 251 amino acids. The recombinant human UNC119B protein is often expressed in Escherichia coli and purified using conventional chromatography techniques . The protein is typically tagged with a His-tag at the N-terminus to facilitate purification and detection .

Functional Role

UNC119B plays a crucial role in the retina, where it is involved in the function of photoreceptor cells. It can functionally complement the C. elegans unc119 mutation gene, indicating its evolutionary conservation and importance . The protein is associated with the mammalian multisubunit photoreceptor cGMP phosphodiesterase PDE alpha beta gamma 2 (PDE6 family), which is a peripherally membrane-associated enzyme .

Applications

Recombinant human UNC119B protein is used in various research applications, including SDS-PAGE and mass spectrometry (MS). It is important to note that this protein is for research use only and is not approved for use in humans or in clinical diagnosis .

Storage and Handling

The recombinant human UNC119B protein should be stored at 4°C for short-term use and at -20°C for long-term storage. It is recommended to avoid freeze-thaw cycles to maintain the protein’s stability and functionality .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.